Cipla Limited is an Indian-based pharmaceutical company. The Company is focused on developing new drug formulations for existing and active drug substances. During the fiscal year ended March 31, 2009, the Company launched many new drugs and formulations, which include Abamune L (abacavir and lamivudine tablets), a nucleoside reverse transcriptase inhibitor (NRTI) combination for human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS); Aprepit (aprepitant capsules), a antiemetic for prevention of nausea and vomiting in cancer chemotherapy; Cold Spray (azelastine and budesonide spray), a combination spray for allergic rhinitis; Corvela (ranolazine tablets), a antianginal and antischaemic agent; Crisanta LS (drosperinone and ethinyl estradiol tablets), a oral contraceptive pill, and Desirox (deferasirox tablets), an iron chelator for thalassaemia.